Joanne Wilson

3.2k total citations
27 papers, 1.2k citations indexed

About

Joanne Wilson is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Joanne Wilson has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Joanne Wilson's work include PARP inhibition in cancer therapy (6 papers), DNA Repair Mechanisms (5 papers) and Lanthanide and Transition Metal Complexes (4 papers). Joanne Wilson is often cited by papers focused on PARP inhibition in cancer therapy (6 papers), DNA Repair Mechanisms (5 papers) and Lanthanide and Transition Metal Complexes (4 papers). Joanne Wilson collaborates with scholars based in United Kingdom, United States and Singapore. Joanne Wilson's co-authors include Michael Briskin, D J Ringler, Nancy A. Cochran, Dawn Winsor-Hines, Nasim Kassam, Charles R. Mackay, Eugene C. Butcher, Stuart Bloom, Walter Newman and David Parker and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Journal of Controlled Release.

In The Last Decade

Joanne Wilson

25 papers receiving 1.2k citations

Peers

Joanne Wilson

IMMUN

GENET

ONCOL

Serena Marchiò Italy

Zhonglin Hao United States

Stefania Lanzardo Italy

Mozhdeh Sojoodi United States

Marlon R. Veldwijk Germany

Wilson B. Edwards United States

Derek W. Bartlett United States

Zhiwei Xu China

Hsin-Ell Wang Taiwan

Serena Marchiò Italy

Joanne Wilson

990 ×2.9

285 ×1.0

IMMUN

74 ×0.3

GENET

494 ×1.8

ONCOL

124 ×0.6

Citations per year, relative to Joanne Wilson Joanne Wilson (= 1×) peers Serena Marchiò

Countries citing papers authored by Joanne Wilson

Since Specialization

Citations

This map shows the geographic impact of Joanne Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne Wilson more than expected).

Fields of papers citing papers by Joanne Wilson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne Wilson. The network helps show where Joanne Wilson may publish in the future.

Co-authorship network of co-authors of Joanne Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne Wilson. A scholar is included among the top collaborators of Joanne Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne Wilson. Joanne Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Colclough, Nicola, Scott E. Martin, Martin Wild, et al.. (2025). Achieving human brain exposure with the oral ataxia-telangiectasia mutated kinase inhibitor AZD1390, a substrate of aldehyde oxidase. Drug Metabolism and Disposition. 53(8). 100107–100107. 1 indexed citations

Decio, Alessandra, Mark R. Albertella, Joanne Wilson, et al.. (2023). The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin. Cancer Research Communications. 3(3). 489–500. 9 indexed citations

Anastasia, Alessia, Antonio Ramos‐Montoya, Giovanna Chiorino, et al.. (2022). The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases. Molecular Cancer Therapeutics. 21(4). 555–567. 25 indexed citations

Staniszewska, Anna D., Domenic Pilger, Giuditta Illuzzi, et al.. (2022). DDDR-01. AZD9574 IS A NOVEL, BRAIN PENETRANT PARP-1 SELECTIVE INHIBITOR WITH ACTIVITY IN AN INTRACRANIAL XENOGRAFT MODEL OF TRIPLE NEGATIVE BREAST CARCINOMA WITH HOMOLOGOUS RECOMBINATION REPAIR DEFICIENCY. Neuro-Oncology. 24(Supplement_7). vii98–vii98. 2 indexed citations

Farooqi, Ahsan, Thinh H. Nguyen, Ashly Hindle, et al.. (2021). ALT neuroblastoma chemoresistance due to telomere dysfunction–induced ATM activation is reversible with ATM inhibitor AZD0156. Science Translational Medicine. 13(607). 40 indexed citations

O’Connor, Lenka Oplustil, Grégory Hamm, Stephanie Ling, et al.. (2020). Abstract 6168: Characterization of ATM inhibitor (AZD1390) distribution and pharmacodynamic changes in brain and glioblastoma in preclinical models to inform on mechanism of action. Cancer Research. 80(16_Supplement). 6168–6168. 1 indexed citations

Reddy, Venkatesh Pilla, Barry Jones, Nicola Colclough, et al.. (2018). An Investigation into the Prediction of the Plasma Concentration-Time Profile and Its Interindividual Variability for a Range of Flavin-Containing Monooxygenase Substrates Using a Physiologically Based Pharmacokinetic Modeling Approach. Drug Metabolism and Disposition. 46(9). 1259–1267. 10 indexed citations

Decaudin, Didier, Rania El Botty, Gérald Massonnet, et al.. (2018). Selumetinib-based therapy in uveal melanoma patient-derived xenografts. Oncotarget. 9(31). 21674–21686. 18 indexed citations

Jones, Barry, Abhishek Srivastava, Nicola Colclough, et al.. (2017). An Investigation into the Prediction of In Vivo Clearance for a Range of Flavin-containing Monooxygenase Substrates. Drug Metabolism and Disposition. 45(10). 1060–1067. 23 indexed citations

10.

Delpuech, Oona, Claire Rooney, Lorraine Mooney, et al.. (2016). Identification of Pharmacodynamic Transcript Biomarkers in Response to FGFR Inhibition by AZD4547. Molecular Cancer Therapeutics. 15(11). 2802–2813. 18 indexed citations

11.

Toy, Weiyi, Hazel M. Weir, Pedram Razavi, et al.. (2016). Activating ESR1 Mutations Differentially Affect the Efficacy of ER Antagonists. Cancer Discovery. 7(3). 277–287. 269 indexed citations

12.

England, R., Jennifer I. Hare, Joanne Wilson, et al.. (2016). Tumour regression and improved gastrointestinal tolerability from controlled release of SN-38 from novel polyoxazoline-modified dendrimers. Journal of Controlled Release. 247. 73–85. 39 indexed citations

13.

Schuller, Alwin G., Evan Barry, Rhys D.O. Jones, et al.. (2015). The MET Inhibitor AZD6094 (Savolitinib, HMPL-504) Induces Regression in Papillary Renal Cell Carcinoma Patient–Derived Xenograft Models. Clinical Cancer Research. 21(12). 2811–2819. 57 indexed citations

14.

Barry, Simon T., Elaine Cadogan, Rajesh Odedra, et al.. (2014). Abstract 5409: AZD1152-hQPA Accurins: Nanoparticle formulations showing extended release and the potential for improved therapeutic index. Cancer Research. 74(19_Supplement). 5409–5409. 2 indexed citations

15.

Luca, Elena De, Peter Harvey, Anurag Mishra, et al.. (2013). Characterisation and evaluation of paramagnetic fluorine labelled glycol chitosan conjugates for 19F and 1H magnetic resonance imaging. JBIC Journal of Biological Inorganic Chemistry. 19(2). 215–227. 38 indexed citations

16.

Harvey, Peter, Andrew M. Blamire, Joanne Wilson, et al.. (2013). Moving the goal posts: enhancing the sensitivity of PARASHIFT proton magnetic resonance imaging and spectroscopy. Chemical Science. 4(11). 4251–4251. 45 indexed citations

17.

Nilsson, Mikael, Christian Danielsson, Ann‐Cathrine Johansson, et al.. (2010). Improved methodology for identifying the teratogenic potential in early drug development of hERG channel blocking drugs. Reproductive Toxicology. 29(2). 156–163. 15 indexed citations

18.

Luca, Elena De, Alan M. Kenwright, Ilya Kuprov, et al.. (2009). Design Principles and Theory of Paramagnetic Fluorine‐Labelled Lanthanide Complexes as Probes for ¹⁹F Magnetic Resonance: A Proof‐of‐Concept Study. Chemistry - A European Journal. 16(1). 134–148. 105 indexed citations

19.

Briskin, Michael, Dawn Winsor-Hines, Nancy A. Cochran, et al.. (1997). Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue.. PubMed. 151(1). 97–110. 421 indexed citations

20.

Bleasdale, Christine, et al.. (1996). Studies on the molecular toxicology of buta-1,3-diene and isoprene epoxides. Toxicology. 113(1-3). 290–293. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact